HC-030031
HC-030031 is a chemical compound that is known for its role as a selective TRPA1 antagonist. It is often used in pharmacology and neuroscience research to study the function and role of TRPA1 channels in various physiological and pathological processes.
Chemistry[edit | edit source]
HC-030031 is a small molecule with a molecular weight of 351.4 g/mol. It is a synthetic compound that is not naturally occurring. The chemical structure of HC-030031 includes a pyrimidine ring, which is thought to contribute to its ability to bind to and inhibit TRPA1 channels.
Pharmacology[edit | edit source]
In pharmacology, HC-030031 is used as a tool to study the TRPA1 channel. The TRPA1 channel is a member of the transient receptor potential (TRP) channel family, which are non-selective cation channels that are involved in various physiological processes, including sensory perception and pain sensation.
HC-030031 is a selective antagonist of the TRPA1 channel, meaning it binds to the channel and inhibits its activity. This makes it a valuable tool for studying the role of TRPA1 channels in various physiological and pathological processes, such as pain sensation, inflammation, and respiratory diseases.
Research Applications[edit | edit source]
HC-030031 has been used in various research studies to investigate the role of TRPA1 channels in different physiological and pathological processes. For example, it has been used to study the role of TRPA1 channels in pain sensation and inflammation. In these studies, HC-030031 is often used to inhibit the activity of TRPA1 channels, allowing researchers to study the effects of this inhibition on pain sensation and inflammation.
In addition to its use in pain and inflammation research, HC-030031 has also been used to study the role of TRPA1 channels in respiratory diseases. For example, it has been used to investigate the role of TRPA1 channels in the development of asthma and chronic obstructive pulmonary disease (COPD).
Safety and Toxicity[edit | edit source]
As with any chemical compound, the safety and toxicity of HC-030031 must be considered. While it is generally considered safe for use in research settings, it should be handled with care to avoid accidental ingestion or skin contact. The toxicity of HC-030031 has not been extensively studied, so its effects on human health are not fully known.
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD